Dogwood Therapeutics, Inc. (DWTX) Operating cash flow 2020–2025
Dogwood Therapeutics, Inc. (DWTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$15.6MFY2025 · since FY2020: -$3.9M → -$15.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.6M | -77.7% |
| FY2024 | -$8.8M | -80.5% |
| FY2023 | -$4.9M | +57.5% |
| FY2022 | -$11.5M | +26.9% |
| FY2021 | -$15.7M | -302.8% |
| FY2020 | -$3.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DWTX financial trends
DWTX RevenueDWTX Net incomeDWTX Net marginDWTX Gross profitDWTX Gross marginDWTX Operating incomeDWTX Operating marginDWTX Free cash flowDWTX Capital expendituresDWTX Return on equityDWTX Stock buybacksDWTX Dividends paidDWTX Total assetsDWTX Total liabilitiesDWTX Shareholders’ equityDWTX overview →